Skip to main content

WELLINGTON MANAGEMENT GROUP LLP

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 902219 Boston, MA

Position in AMLX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$3,357,571
+$630,126 QoQ
Shares Held
241,552
+7.0% QoQ
Ownership
0.217%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2022
11 quarters on record
Voting authority Sole 0% Shared 71% None 29%

Common Shares in AMLX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

WELLINGTON MANAGEMENT GROUP LLP holds $3,311,744,758 across 31 Drug Manufacturers - Specialty & Generic names. AMLX ranks #14 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AMLX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,357,571 241,552
2025-12-31 $2,727,445 225,782
2025-09-30 $3,209,915 236,197
2025-06-30 $1,850,040 288,618
2025-03-31 $1,029,013 290,682
2024-12-31 $792,695 209,708
2024-03-31 $96,368 33,933
2023-12-31 $658,763 44,753
2023-06-30 $382,133 17,716
2023-03-31 $3,181,306 108,429
2022-12-31 $2,509,088 67,905